Active Not Recruiting PHASE4 INTERVENTIONAL 1-arm
NCT07250763
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
Optimization of Intravenous Unfractionated Heparin Starting Infusion Rate for Adult Patients With Deep Vein Thrombosis/Pulmonary Embolism or Cardiac Indications
Sponsor: Inova Health Care Services
Conditions
Acute Cardiac Syndrome Atrial Fibrillation Deep Vein Thrombosis Mechanical Heart Valve Recipients Pulmonary Embolism
Interventions
Initial Heparin Dose Modification
Updated 1 time since 2025 Last updated: Nov 25, 2025 Started: Sep 20, 2023 Primary completion: Feb 28, 2027 Completion: May 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE4 trial investigates Acute Cardiac Syndrome and Atrial Fibrillation and is currently ongoing. Inova Health Care Services leads this study, which shows 1 recorded version since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
1 version recorded Active Not Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Inova Health Care Services
Data source: Inova Health Care Services
For direct contact, visit the study record on ClinicalTrials.gov .